GD9
2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-yl-thieno[3,2-d]pyrimidine
Find entries where: GD9
is present as a standalone ligand in 3 entries
Chemical Component Summary | |
---|---|
Name | 2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-yl-thieno[3,2-d]pyrimidine |
Identifiers | 2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]-4-morpholin-4-yl-thieno[2,3-e]pyrimidine |
Formula | C23 H27 N7 O3 S2 |
Molecular Weight | 513.636 |
Type | NON-POLYMER |
Isomeric SMILES | CS(=O)(=O)N1CCN(CC1)Cc2cc3c(s2)c(nc(n3)c4cccc5c4cn[nH]5)N6CCOCC6 |
InChI | InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27) |
InChIKey | LHNIIDJUOCFXAP-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 62 |
Chiral Atom Count | 0 |
Bond Count | 67 |
Aromatic Bond Count | 21 |
Drug Info: DrugBank
DrugBank ID | DB11663 |
---|---|
Name | Pictilisib |
Groups | investigational |
Description | Pictilisib has been used in trials studying the treatment of Solid Cancers, Breast Cancer, Advanced Solid Tumours, Metastatic Breast Cancer, and Non-Hodgkin's Lymphoma, Solid Cancers, among others. |
Synonyms | Pictilisib |
Categories |
|
CAS number | 957054-30-7 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL521851 |
PubChem | 17755052 |
ChEMBL | CHEMBL521851 |
ChEBI | CHEBI:65326 |